Dako Corp.: FDA filings under this applicant name

FDA lists 54 510(k) clearances under the applicant name “Dako Corp.” (first 1981, latest 2002), across 25 product codes in 4 review panels. Median 510(k) review time under this name: 68 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
20120—
20130—
20140—
20150—
20160—
20170—
20180—
20190—
20200—
20210—
20220—
20230—
20240—
20250—
20260—

Top product codes

Product codeDeviceSubmissions510(k) clearances
GKZCounter, Differential Cell1414
DEHLambda, Antigen, Antiserum, Control99
DEWIgg, Antigen, Antiserum, Control44
CZWComplement C3, Antigen, Antiserum, Control33
CZPIga, Antigen, Antiserum, Control22
DBIComplement C4, Antigen, Antiserum, Control22
DFHKappa, Antigen, Antiserum, Control22
CZNIga, Fitc, Antigen, Antiserum, Control11
DADHaptoglobin, Antigen, Antiserum, Control11
DAHGamma Globulin, Antigen, Antiserum, Control11

Plus 15 more product codes.

Review panels

Most recent Dako Corp. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K020023DAKO MONOCLONAL MOUSE ANTI-HUMAN PROGESTERONE RECEPTOR, CLONE PGR 636, ANTIBODY FOR IMMUNOENZYMATIC STAININGMXZ2002-02-2856
K993957DAKO MONOCLONAL MOUSE ANTI-HUMAN ESTROGEN RECEPTORMYA2000-03-03102
K991454MOUSE IGG1 NEGATIVE CONTROLSGKZ1999-06-2156
K991402DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE-CY5, CLONE UCHT1 & DAKO MOUSE ANTI-HUMAN T-CELL, CD3/RPE, CLONE UCHT1GKZ1999-06-2160
K980635DAKO MOUSE ANTI-HUMAN B-CELL, CD19/RPE-CY5, CLONE HD37GKZ1998-07-22153
K971905DAKO MOUSE ANTI HUMAN CYTOKERATIN, HIGH MOLECULAR WEIGHT, CLONE 34BE12, MONOCLONAL ANTIBODY FOR IMMUNOENZYMATIC STAININGDEH1997-12-12203
K965022MONOCLONAL MOUSE ANTI-HUMAN CD30, KI-1 ANTIGEN, BER-H2 ANTIBODY FOR IMMUNOENZYMATIC STAINING (PRODUCT CODE NO. MO751)DEH1997-11-06325
K964974MOUSE ANTI-HUMAN CD45, LEUCOCYTE COMMON ANTIGEN (LCA)/FITC AND CD14, MONOCYTE/RPEGKZ1997-06-24194
K961701MOUSE ANTI-HUMAN CD3, T-CELL, FITC AND CD4, T-CELL, (HELPER/INDUCER) RPEGKZ1996-07-1675
K951965DAKO LABELED STREPTAVIDIN-BIOTIN 2 KIT, AND ENVISIONDEH1996-07-05435

44 earlier clearances. See the full list in Caduvo.

Recalls

openFDA lists no recalls under a recalling firm named Dako Corp..

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Dako Corp. (a text match, not an official crosswalk):

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Dako Corp.?

FDA lists 54 510(k) clearances under the applicant name “Dako Corp.” (first 1981, latest 2002), across 25 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Dako Corp.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Dako Corp. is 68 days.

Which FDA product codes appear under Dako Corp.?

The most frequent FDA product codes under this applicant name are GKZ (Counter, Differential Cell, 14); DEH (Lambda, Antigen, Antiserum, Control, 9); DEW (Igg, Antigen, Antiserum, Control, 4).

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.

All FDA device companies · FDA product code lookup